Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
The Journal of Biological Chemistry
|
February 26, 1999
beta3-adrenoceptor control the cystic fibrosis transmembrane conductance regulator through a cAMP/protein kinase A-independent pathway
V Leblais, S Demolombe, G Vallette, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1992
Positive inotropic effects of RP 62719, a new pure class III antiarrhythmic agent, on guinea pig myocardium
J P Beregi, D Escande, N Coudray, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
February 1, 1994
[Positive inotropic and lusitropic effect of RP 62719, a new class III antiarrhythmia agent]
J P Beregi, D Escande, N Coudray, et al.
The Journal of Gene Medicine
|
April 25, 2001
Ca2+-sensitive cytosolic nucleases prevent efficient delivery to the nucleus of injected plasmids
H Pollard, G Toumaniantz, J L Amos, et al.
The American Journal of Physiology
|
March 5, 1998
Hyperexpression of recombinant CFTR in heterologous cells alters its physiological properties
R Mohammad-Panah, S Demolombe, D Riochet, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 20, 1999
Interspecies differences in the cardiac negative inotropic effects of beta(3)-adrenoceptor agonists
C Gauthier, G Tavernier, J N Trochu, et al.
European Heart Journal
|
February 24, 2001
Dynamic analysis of the QT interval in long QT1 syndrome patients with a normal phenotype
G Lande, F Kyndt, I Baró, et al.
Circulation Research
|
October 1, 1990
Potassium accumulation in the globally ischemic mammalian heart. A role for the ATP-sensitive potassium channel
A A Wilde, D Escande, C A Schumacher, et al.
Biochemical and Biophysical Research Communications
|
August 14, 2001
Inactivating properties of recombinant ROMK2 channels expressed in mammalian cells
D F Riochet, R Mohammad-Panah, S C Hebert, et al.
Gene Therapy
|
August 1, 1996
A method for the rapid detection of recombinant CFTR during gene therapy in cystic fibrosis
S Demolombe, I Baró, Z Bebok, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
The Journal of Biological Chemistry
|
February 26, 1999
beta3-adrenoceptor control the cystic fibrosis transmembrane conductance regulator through a cAMP/protein kinase A-independent pathway
V Leblais, S Demolombe, G Vallette, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1992
Positive inotropic effects of RP 62719, a new pure class III antiarrhythmic agent, on guinea pig myocardium
J P Beregi, D Escande, N Coudray, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
February 1, 1994
[Positive inotropic and lusitropic effect of RP 62719, a new class III antiarrhythmia agent]
J P Beregi, D Escande, N Coudray, et al.
The Journal of Gene Medicine
|
April 25, 2001
Ca2+-sensitive cytosolic nucleases prevent efficient delivery to the nucleus of injected plasmids
H Pollard, G Toumaniantz, J L Amos, et al.
The American Journal of Physiology
|
March 5, 1998
Hyperexpression of recombinant CFTR in heterologous cells alters its physiological properties
R Mohammad-Panah, S Demolombe, D Riochet, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 20, 1999
Interspecies differences in the cardiac negative inotropic effects of beta(3)-adrenoceptor agonists
C Gauthier, G Tavernier, J N Trochu, et al.
European Heart Journal
|
February 24, 2001
Dynamic analysis of the QT interval in long QT1 syndrome patients with a normal phenotype
G Lande, F Kyndt, I Baró, et al.
Circulation Research
|
October 1, 1990
Potassium accumulation in the globally ischemic mammalian heart. A role for the ATP-sensitive potassium channel
A A Wilde, D Escande, C A Schumacher, et al.
Biochemical and Biophysical Research Communications
|
August 14, 2001
Inactivating properties of recombinant ROMK2 channels expressed in mammalian cells
D F Riochet, R Mohammad-Panah, S C Hebert, et al.
Gene Therapy
|
August 1, 1996
A method for the rapid detection of recombinant CFTR during gene therapy in cystic fibrosis
S Demolombe, I Baró, Z Bebok, et al.
Page
of 7